Search

Displaying results 5901 - 5910 of 10000 in total
  1. Drug

    Ferroheme C

    go.drugbank.com/drugs/DB03317
    Experimental

    Categories: Heterocyclic Compounds with 4 or More Rings
  2. Drug

    Mizacorat

    go.drugbank.com/drugs/DB21458
    Investigational

    Mizacorat has a monoisotopic molecular weight of 494.21 Da. … Mizacorat is under investigation in clinical trial NCT04556760 (Study to Assess the Effect on Glucose Homeostasis of Two Dose Levels of AZD9567, Compared to Prednisolone, in Adults With Type 2 Diabetes

  3. Drug

    Docirbrutinib

    go.drugbank.com/drugs/DB21606
    Investigational

    Docirbrutinib has a monoisotopic molecular weight of 578.24 Da. … Docirbrutinib is under investigation in clinical trial NCT05602363 (AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma).

  4. Drug

    Verdoheme

    go.drugbank.com/drugs/DB04803
    Experimental

    Categories: Heterocyclic Compounds with 4 or More Rings
  5. Drug

    Heme D

    go.drugbank.com/drugs/DB03469
    Experimental

    Categories: Heterocyclic Compounds with 4 or More RingsSynonyms: Heme D
  6. Drug

    (R)-methylmalonyl-CoA

    go.drugbank.com/drugs/DB04045
    Investigational

    Categories: Thioesters of coenzyme A
  7. Drug

    Propanoyl-CoA

    go.drugbank.com/drugs/DB02912
    Experimental

    Categories: Thioesters of coenzyme A
  8. Drug

    Talampanel

    go.drugbank.com/drugs/DB04982
    Investigational

    Talampanel is a substance that is being studied in the treatment of brain tumors and other brain disorders, such as epilepsy and Parkinson disease. It is a type of AMPA receptor antagonist.

  9. Drug

    Aceprometazine

    go.drugbank.com/drugs/DB01615
    Experimental

    Although not widely prescribed, it is used in combination with meprobamate for the treatment of sleep disorders in France under the trade name Mepronizine.

  10. Drug

    Azimilide

    go.drugbank.com/drugs/DB04957
    Investigational

    Azimilide is an investigational class III anti-arrhythmic drug that blocks fast and slow components of the delayed rectifier cardiac potassium channels. … It is not approved for use in any country, but is currently in clinical trials in the United States.